Hepatotoxic and cellular uptake interactions among surface active components of erythromycin preparations
- 1 January 1978
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 27 (15) , 1925-1930
- https://doi.org/10.1016/0006-2952(78)90007-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Lymphocyte Cytotoxicity in Alcoholic HepatitisGastroenterology, 1977
- Possible Hepatotoxicity of Doxidan®Annals of Internal Medicine, 1976
- Liver cell culture toxicity and surfactant potency of erythromycin derivativesToxicology and Applied Pharmacology, 1975
- Efficacy and Specificity of Chenodeoxycholic Acid Therapy for Dissolving GallstonesNew England Journal of Medicine, 1973
- Drug-induced active chronic hepatitisDigestive Diseases and Sciences, 1973
- Potentiation of the antitumour effect of rubidomycin and rubomycin by non-ionic detergentsPublished by Elsevier ,1972
- Toxicity of a hepatotoxic laxative preparation in tissue culture and excretion in bile in manClinical Pharmacology & Therapeutics, 1972
- Para‐ Aminophenol Metabolism in an Established Cell Line with Liver‐like FunctionsActa Pharmacologica et Toxicologica, 1972
- HEPATIC DYSFUNCTION ASSOCIATED WITH TRIACETYLOLEANDOMYCIN AND PROPIONYL ERYTHROMYCIN ESTER LAURYL SULFATEThe Lancet Healthy Longevity, 1962